EFFECT OF 5-(P HYDROXYPHENYL)-5-PHENYLHYDANTOIN (P-HPPH) ENANTIOMERS,MAJOR METABOLITES OF PHENYTOIN, ON THE OCCURRENCE OF CHRONIC-GINGIVALHYPERPLASIA - IN-VIVO AND IN-VITRO STUDY
I. Ieiri et al., EFFECT OF 5-(P HYDROXYPHENYL)-5-PHENYLHYDANTOIN (P-HPPH) ENANTIOMERS,MAJOR METABOLITES OF PHENYTOIN, ON THE OCCURRENCE OF CHRONIC-GINGIVALHYPERPLASIA - IN-VIVO AND IN-VITRO STUDY, European Journal of Clinical Pharmacology, 49(1-2), 1995, pp. 51-56
The purpose of this study was to assess the possible role of the (R)-
and (S)- enantiomers of the phenytoin metabolite p-HPPH in the pathoge
nesis of gingival hyperplasia (GH). About 98% of circulating p-HPPH is
in the (S)-form. There were significant differences between patients
with and without GH in (R)p-HPPH level (0.055 vs 0.042 mu g . ml(-1)),
both enantiomer/racemate level ratios, and R/S enantiomeric ratio (0.
0313 vs 0.0232); an increase in serum (R)-p-HPPH level was observed in
patients with GH. In separate experiments, the effect of p-HPPH enant
iomers on the proliferation of the normal human dermal fibroblast was
studied. The in vitro study showed that (R)-p-HPPH selectively stimula
ted fibroblast growth. The results suggest that the least abundant met
abolite, (R)-p-HPPH, is the most toxic with respect to gingival hyperp
lasia.